Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Sodium bicarbonate (NaHCO) is a well-established nutritional ergogenic aid that is typically ingested as a beverage or consumed in gelatine capsules. While capsules may delay the release of NaHCO and reduce gastrointestinal (GI) side effects compared with a beverage, it is currently unclear whether the capsule size may influence acid-base responses and GI symptoms following supplementation. This study aims to determine the effects of NaHCO supplementation, administered in capsules of different sizes, on acid-base responses, GI symptoms, and palatability. Ten healthy male subjects (mean ± SD: age 20 ± 2 years; height 1.80 ± 0.09 m; weight 78.0 ± 11.9 kg) underwent three testing sessions whereby 0.3 g NaHCO/kg of body mass was consumed in either small (size 3), medium (size 0), or large (size 000) capsules. Capillary blood samples were procured pre-ingestion and every 10 min post-ingestion for 180 min. Blood samples were analyzed using a radiometer (Radiometer ABL800, Denmark) to determine blood bicarbonate concentration ([ ]) and potential hydrogen (pH). GI symptoms were measured using a questionnaire at the same timepoints, whereas palatability was recorded pre-consumption. Capsule size had a significant effect on lag time (the time [ ] changed, ) and the timing of peak blood [ ] ( ). Bicarbonate was significantly higher in the large-sized (28 ± 4 min) compared with the small-sized (13 ± 2 min) capsules ( = 0.009). Similarly, was significantly lower in the small capsule (94 ± 24 min) compared with both the medium-sized (141 ± 27 min; < 0.001) and the large-sized (121 ± 29 min; < 0.001) capsules. The GI symptom scores were similar for small-sized (3 ± 3 AU), medium-sized (5 ± 3 AU), and large-sized (3 ± 3 AU) capsules, with no significant difference between symptom scores ( = 1.3, = 0.310). Similarly, capsule size had no effect on palatability ( = 0.8, = 0.409), with similar scores between different capsule sizes. Small capsule sizes led to quicker and of blood [ ] concentration compared to medium and large capsules, suggesting that individuals could supplement NaHCO in smaller capsules if they aim to increase extracellular buffering capacity more quickly.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933015 | PMC |
http://dx.doi.org/10.3389/fnut.2021.634465 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!